Patient Case Study
To protect patient confidentiality, no specific
patient identifiers are listed in this account.
A 34
year old woman from
Her
medical history indicated that her symptoms started five years ago, with
cramping and spasms of her arms. She noted that her wrists felt like they were
falling asleep at times, along with needle-like pain that would occasionally
erupt. Additionally, she reported a significant amount of fatigue and stress.
The patient’s medical record indicated a diagnosis with depression; her initial
visits for the skin condition included initial diagnoses of atopic
dermatitis and urticaria before the biopsy was taken. The patient was prescribed ibuprofen, fluoxetine and hydroxyzine.
During
the course of the interview, the patient revealed that she had worked with
flowers extensively several years ago while in the United States, which
presents a possible exposure to the M. leprae
bacterium; furthermore, she reported that armadillos were endemic in her home
in South America and that her family kept a variety of household pets such as
dogs and birds. The interview was unable to determine if any other family
members, locally or out-of-state, had similar dermatological complaints;
however, her infant reportedly had a fungal infection suggesting potential
infection of the child.
The
physical exam revealed numerous lesions throughout her body, including those on
her nasal bridge area, cheeks, abdomen and back. These lesions were macular in
nature and did not exhibit significant plaque, dryness or significant
discoloration other than an erythematous appearance.
The soles of her feet appeared to be usually dry and callous, and her legs
appeared hypopigmented when compared to the rest of
the body. The eyebrows appeared to have started thinning. Her reflexes were hyperreflexive and her forearm demonstrated some
anesthesia, corresponding to the ulnar nerve.
The
patient was counseled about leprosy, and a course of multi-drug theraphy combining dapsone
(100mg/ day), clofazimine (50mg/ day) and rifampin (600mg/monthly) was prescribed for a period of 2
years. The monthly dose of rifampin would be taken
under supervision to ensure compliance and to track any adverse effects. Liver
function tests were ordered to ensure hepatotoxicity
did not result from her concurrent use of other medications.
As
required by county law, the patient’s case was reported to the Public Health
Department using established protocols.